Amendment 0001.pdf

This document is an amendment to Solicitation HT9402-24-Q-9404 for the Department of Defense (DoD) Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program. The purpose of this modification is to update the solicitation by adding price lists for two newly approved drugs, Aqneursa (Neurological Agents Miscellaneous) and Cobenfy (Antipsychotic Agents - Atypical), to be considered at the November 2024 Pharmacy and Therapeutics (P&T) Committee meeting. The solicitation is seeking quotes from industry for pharmaceutical agents within drug classes identified for placement on the DoD Uniform Formulary. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the P&T Committee's decisions. The pre-quotation teleconference is scheduled for October 2, 2024, and responses to clinical questions are due by the date stated in the solicitation.